Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
HSDTthis companySolana Company	$1.88	-1.56×	0.21×	10.59×	-1.43×	-610.6%	91.7%	-351.0%	-679.6%	-13.6%	-7.0%	-96.2%	0×	0.18×	-33.26×	10.33×	0.0%	3	1.76	1	C-
CATXPerspective Therapeutics, Inc.	$0.86	-1.96×	0.98×	0×	-1.74×	-87.1%	0.0%	0.0%	0.0%	-49.8%	-47.2%	-46.9%	0.02×	0.27×	-302.03×	5.17×	0.0%	3	-0.5	3	B-
ELMDElectromed, Inc.	$27.08	30.88×	6.48×	4.74×	22.02×	-45.6%	78.5%	18.8%	15.3%	20.9%	20.2%	2.4%	0×	-1.36×	0×	4.69×	0.0%	7	14.18	4	A
INFUInfuSystem Holdings, Inc.	$14.39	28.03×	3.23×	1.29×	7.36×	-53.4%	56.0%	8.3%	4.6%	11.6%	9.3%	8.5%	0.06×	0.01×	9.18×	1.8×	0.0%	9	5.68	3	B+
INGNInogen, Inc.	$5.98	-7.91×	0.95×	0.52×	-35.43×	-203.4%	47.6%	-8.7%	-6.5%	-11.8%	-12.3%	-11.8%	0.09×	31.71×	0×	3.12×	0.0%	3	1.53	2	C
OMOutset Medical, Inc.	$4.20	-0.69×	0.44×	0.47×	-1.97×	-1772.3%	39.1%	-55.8%	-68.3%	-64.3%	-29.2%	-83.5%	0.8×	-1.06×	-4.78×	6.67×	0.0%	3	-6.08	2	C
Peer median	—	-0.69×	0.98×	0.52×	-1.74×	-87.1%	47.6%	0.0%	0.0%	-11.8%	-12.3%	-11.8%	0.06×	0.01×	0×	4.69×	0.0%	3	1.53	3	—